Evaluation of clinical efficacy of transdermal Tulobuterol to the small airway dysfunction in patient with COPD.
Not Applicable
- Conditions
- COPD(Chronic Obstructive Pulmonary Disease)
- Registration Number
- JPRN-UMIN000006256
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient of the symptom that bronchial asthma is main. 2)Patient who takes oral corticosteroid. 3)Patient who uses home oxygen therapy. 4)Patients with a history of hypersensitivity to Tulobuterol. 5)Patient who was considered ineligible to use transdermal Tulobuterol in a patient having skin diseases such as atopic dermatitis. 6)Patient who was considered ineligible to use bata2 agonist in a patient complicated with hyperthyroidism, hypertension, heart disease and diabetes mellitus. 7)Woman who are pregnant or breast feeding, and woman of childbearing potential. 8)Patient who was considered ineligible by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method